the role of lymphodepletion in car t-cell therapy: current knowledge & the need for personalization
Published 9 months ago • 395 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
1:18
the importance of lymphodepletion, an undervalued component of the car-t therapy cycle
-
4:44
optimizing lymphodepletion chemotherapy in car-t therapy recipients
-
2:16
autosct vs car-t for patients with relapsed lbcl in pr: the role of total metabolic tumor volume
-
1:50
outcomes of patients with dlbcl following asct and/or car-t
-
0:44
the role of allosct for r/r lbcl in the era of car-t therapy
-
5:09
the evolving role of nurses in the field of car-t
-
1:39
the role of myeloid cells in car-t cell therapy
-
2:53
results from a phase i study of rapcabtagene autoleucel (ytb323), a novel car-t therapy in dlbcl
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
2:33
the effect of lymphodepleting agents on rate and severity of toxicities following car-t infusion
-
0:57
zamtocabtagene autoleucel: mechanism of production & potential implications for access
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
0:52
the role of transplantation for patients with mcl in the era of car-t therapy
-
2:48
outcomes of autosct, allosct & car-t cell therapy in patients with tp53-altered mcl
-
2:50
state of the art in car-t
-
2:03
cellular kinetics of car-t & prophylactic promise
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
0:53
anti-cd7 car-t therapy for t-all/lbl
-
1:09
car-t for cll